Ikarian Capital, LLC Celldex Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

$573 Million
Q3 2024

A detailed history of Ikarian Capital, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 305,500 shares of CLDX stock, worth $7.57 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares

305,500

Holding current value

$7.57 Million

% of portfolio

1.81%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $5.61 Million - $7.66 Million	-161,419 Reduced 60.35%	106,057 $3.82 Million
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $1.39 Million - $2.27 Million	-50,000 Reduced 15.75%	267,476 $11.9 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $5 Million - $8.28 Million	-220,482 Reduced 40.98%	317,476 $8.92 Million
Q1 2022 May 13, 2022	BUY	$27.64 - $39.32 $3.28 Million - $4.67 Million	118,742 Added 28.32%	537,958 $18.3 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $5.31 Million - $8.37 Million	148,785 Added 55.02%	419,216 $16.2 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $2.75 Million - $5.33 Million	-95,113 Reduced 26.02%	270,431 $14.6 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $4.78 Million - $8.16 Million	-230,746 Reduced 38.7%	365,544 $12.2 Million
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $12.4 Million - $23 Million	-768,700 Reduced 56.32%	596,290 $12.3 Million
Q4 2020 Feb 12, 2021	SELL	$14.99 - $22.75 $1.57 Million - $2.38 Million	-104,740 Reduced 7.13%	1,364,990 $23.9 Million
Q3 2020 Nov 16, 2020	SELL	$9.65 - $15.19 $1.71 Million - $2.7 Million	-177,709 Reduced 10.79%	1,469,730 $21.8 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $2.65 Million - $22.1 Million	1,647,439 New	1,647,439 $21.4 Million

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.16B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Account

Ikarian Capital, LLC Celldex Therapeutics, Inc. Transaction History